CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer

CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer

Medullary thyroid cancer (MTC) is a rare malignancy, and the treatment of metastatic MTC is challenging. In previous work, immune profiling (RNA-Seq) of MTC identified CD276 as a potential target for immunotherapy. CD276 expression was 3-fold higher in MTC cells than in normal tissues. Paraffin bloc...

Full description

Bibliographic Details
Main Authors: Kinga Hińcza-Nowak, Artur Kowalik, Agnieszka Walczyk, Iwona Pałyga, Danuta Gąsior-Perczak, Agnieszka Płusa, Janusz Kopczyński, Magdalena Chrapek, Stanisław Góźdź, Aldona Kowalska
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:International Journal of Molecular Sciences
Subjects:
CD276
immunotherapy
medullary thyroid cancer
Online Access:https://www.mdpi.com/1422-0067/24/12/10019

Internet

https://www.mdpi.com/1422-0067/24/12/10019

Similar Items